Metraipolis › archive › dc_deb0bec85d0e

Allergen Immunotherapy and 36-Month Allergic Respiratory Disease Trajectories: A Target-Trial — Europe PMC PMID:42934766

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42934766
DOI
10.1002/iid3.70569
License (as archived)
solo-consultazione
Archived
2026-11-01T09:24:18.292Z
SHA-256 of the archived text
9c25186c8016e73611b28a60609e226ac19554ecc43ca73c4130ed87c19d7b45
Stable URL of this page
https://metraipolis.com/documento/dc_deb0bec85d0e

How to cite

Allergen Immunotherapy and 36-Month Allergic Respiratory Disease Trajectories: A Target-Trial — Europe PMC PMID:42934766 — Europe PMC (en), https://europepmc.org/article/MED/42934766 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_deb0bec85d0e (Metraipolis archive dc_deb0bec85d0e, sha256 9c25186c8016e73611b28a60609e226ac19554ecc43ca73c4130ed87c19d7b45)
BibTeX
@misc{dcdeb0bec85d0e,
  title = {Allergen Immunotherapy and 36-Month Allergic Respiratory Disease Trajectories: A Target-Trial — Europe PMC PMID:42934766},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42934766},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_deb0bec85d0e; sha256 9c25186c8016e73611b28a60609e226ac19554ecc43ca73c4130ed87c19d7b45},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42934766. Agents can read the archived copy with the MCP tool read_document.